December 27, 2024

11 Medical Breakthroughs This Year

Explore medical breakthroughs from 2024, including advancements in Parkinson’s therapy, ulcerative colitis treatments, and gene therapy for hereditary deafness.

Conexiant

December 27, 2024

FDA Approves Injectable Opdivo Version

The FDA has approved an injectable version of a popular cancer drug developed by Bristol Myers Squibb.

Reuters

December 26, 2024

FDA Proposes Asbestos Testing in Talc

The FDA is proposing a rule to require standardized asbestos testing in talc-containing cosmetics, aiming to reduce health risks linked to asbestos exposure. Johnson & Johnson is facing lawsuits related to asbestos-contaminated talc, while the FDA seeks input on the proposed rule from healthcare professionals and the public.

Reuters

December 26, 2024

Tattoo Ink Helps Successfully Remove Lymph Nodes

Tattoo ink localization achieved 94% surgical success in axillary node removal.

Conexiant

December 23, 2024

Coffee, Tea May Alter Head-Neck Cancer Risk

An updated pooled analysis of 9,548 head and neck cancer cases and 15,783 controls, conducted by the International Head and Neck Cancer Epidemiology Consortium, revealed significant associations.

Conexiant

December 20, 2024

Advanced Breast Cancer Cases Rising in U.S.

The incidence of late-stage, invasive breast cancer has risen significantly across all age groups and ethnicities in the U.S. from 2004 to 2021, emphasizing the critical need for enhanced breast cancer screening and early detection.

Reuters

December 20, 2024

Is Surgery Necessary for Low-Risk DCIS?

“If these results hold up over time, most patients who have this type of low-risk disease will have the option of avoiding invasive treatments."

Reuters

December 18, 2024

Darzalex May Delay Myeloma in High-Risk Patients

For the first time, we have a treatment option that can significantly delay or prevent the progression to active disease."

Reuters

December 18, 2024

Physicians With Kids Face Large Pay Gaps

Physician compensation remains a central concern in health care, influenced by educational debt, specialty-specific variations, and evolving employer policies.

Conexiant